CSI Market
Sign In | Register

Elicio Therapeutics Inc (ELTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access ELTX quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Elicio Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent18.56
Other Short-term Investments0.00
Cash & Short-term Investments18.00
Notes Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.75
Total Current Assets19.31
Equipment/Property/Plant Net0.30
Long-term investments0.00
Tax Assets, Noncurrent0.00
Prepaid Expense Other, Noncurrent PR0.77
Other Assets, Noncurrent5.49
Restricted Cash Current-
Operating Lease Right Of Use Asset4.78
Total Assets25.86
Liabilities
Accounts Payable, Current AC0.67
Accrued Liabilities, Current AC6.43
Other Liabilities, Current1.01
Deferred Compensation Share-based Arrangements, Liability, Current DE10.00
Total Current Liabilities8.11
Long-term debt9.41
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt9.41
Financial Instruments, Insurance, Noncurrent0.00
Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent6.71
Operating Lease Liability Current1.01
Contract With Customer Liability Current-
Warrant Liability Current-
Operating Lease Liability Noncurrent4.09
Total Liabilities24.23
Stockholders' Equity
Treasury Stock Common Value-0.15
Common Stock Value0.18
Additional Paid In Capital Common Stock235.41
Retained Earnings / Accumulated Deficit-233.67
Other Equity-0.13
Common Stockholder's Equity1.64
Non-controlling interests & other0.00
Total Stockholder's Equity1.64
Liabilities & Stockholder's Equity25.86
4 historic quarters locked

Sign in to unlock the full Elicio Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Elicio Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001601485-26-000027

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License